Sage Journals: Discover world-class research

Open access

Brief report

First published 2025

Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC)

Mazyar Shadman, Jennifer R. Brown, Rhys Williams [...]

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2024

Successful treatment of hemophagocytic intravascular large B-cell lymphoma with CNS involvement with BTK inhibitor combined with rituximab and high-dose methotrexate

Fangfei Shao, Wei Su, Xiujie Zhao [...]

Therapeutic Advances in Hematology

Retricted access

Case report

First published 2024-12

CNS Aspergillosis and Cryptococcosis with Cytomegalovirus Pneumonia in a Patient with Chronic Lymphocytic Leukemia Treated with Acalabrutinib

Taylor Fallin, Erica Thacker, Syeda Sahra [...]

Journal of Pharmacy Practice

Free access

Research article

First published 2018-6

Pancreatic Effects of a Bruton’s Tyrosine Kinase Small-molecule Inhibitor in Rats Are Strain-dependent

Manoj Bhaskaran, Paul D. Cornwell, Steven D. Sorden [...]

Toxicologic Pathology

Free access

Review article

First published 2024-1

Pirtobrutinib: A novel non-covalent BTK inhibitor for the treatment of adults with relapsed/refractory mantle cell lymphoma

Dominique D Davis, Zahava Ohana, Huy M Pham

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2022

Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib

Jérôme Paillassa, Firas Safa, Xavier Troussard

Therapeutic Advances in Hematology

Retricted access

Case report

First published 2023

Hypophosphatemia related to the use of ibrutinib

Mine Karadeniz, Olgu Erkin Cinar, Batuhan Erdogdu [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2019-12

Bruton’s Tyrosine Kinase Inhibition Promotes Myelin Repair

Elodie Martin, Marie-Stéphane Aigrot, Roland Grenningloh [...]

Brain Plasticity

Open access

Research article

First published 2024

Comparative safety of novel targeted therapies in relapsed/refractory chronic lymphocytic leukemia: a network meta-analysis

Magdalena Monica, Monika Reczek, Paweł Kawalec

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Ibrutinib oral suspension bioavailability and compatibility for optimal enteral administration route

Jonas Paludo, Lisa Nodzon, Xavier Woot de Trixhe [...]

Therapeutic Advances in Hematology

Search results